Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial

Background: Olfactory training is the only evidence-based treatment for post-viral olfactory dysfunction. Smell disorders after SARS-CoV-2 infection have been attributed to neuroinflammatory events within the olfactory bulb and the central nervous system. Therefore, targeting neuroinflammation is on...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Stadio, Arianna, D’Ascanio, Luca, Vaira, Luigi Angelo, Cantone, Elena, De Luca, Pietro, Cingolani, Cristina, Motta, Gaetano, De Riu, Giacomo, Vitelli, Federica, Spriano, Giuseppe, De Vincentiis, Marco, Camaioni, Angelo, La Mantia, Ignazio, Ferreli, Fabio, Brenner, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886808/
https://www.ncbi.nlm.nih.gov/pubmed/35450527
http://dx.doi.org/10.2174/1570159X20666220420113513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886808/
https://www.ncbi.nlm.nih.gov/pubmed/35450527
http://dx.doi.org/10.2174/1570159X20666220420113513

Ejemplares similares